Early Access

Back to LLY

ELI LILLY & Co Cash & Equivalents 2006-2025 | LLY

Beta

What is cash & equivalents?

Cash and cash equivalents can be defined as the most liquid assets on a company's balance sheet, including cash on hand and short-term investments maturing within 90 days.

What is ELI LILLY & Co's current cash & equivalents?

ELI LILLY & Co (LLY) annual cash & equivalents for 2025 was $7.27B, a 122.40% increase from 2024. ELI LILLY & Co cash & equivalents for the quarter ending December 31, 2025 was $7.27B.

What was ELI LILLY & Co's cash & equivalents in 2024?

ELI LILLY & Co annual cash & equivalents for 2024 was $3.27B, a 15.94% increase from 2023.

What was ELI LILLY & Co's cash & equivalents in 2023?

ELI LILLY & Co annual cash & equivalents for 2023 was $2.82B, a 36.36% increase from 2022.

What is ELI LILLY & Co's 5-year cash & equivalents CAGR?

ELI LILLY & Co cash & equivalents grew at a compound annual growth rate (CAGR) of 14.72% from FY2020 to FY2025, going from $3.66B to $7.27B over 5 years.

Cash & Equivalents History

Year-over-year comparison from 10-K annual reports

Key Statistics
Trend Direction
Growing
CAGR+14.7%
FY2020
$3.66B
→
FY2025
$7.27B
0607080910111213141516171819202122232425
5 years selected
Cash & Equivalents History
PeriodValueChangeSource
FY2025$7.27B+122.4%10-K
FY2024$3.27B+15.9%10-K
FY2023$2.82B+36.4%10-K
FY2022$2.07B-45.9%10-K
FY2021$3.82B+4.4%10-K
FY2020$3.66B+56.5%10-K
FY2019$2.34B-68.1%10-K
FY2018$7.32B+12.0%10-K
FY2017$6.54B+42.6%10-K
FY2016$4.58B+25.0%10-K
FY2015$3.67B-5.3%10-K
FY2014$3.87B+1.1%10-K
FY2013$3.83B-4.7%10-K
FY2012$4.02B-32.1%10-K
FY2011$5.92B-1.2%10-K
FY2010$5.99B+34.3%10-K
FY2009$4.46B-18.8%10-K
FY2008$5.50B+70.7%10-K
FY2007$3.22B+3.6%10-K
FY2006$3.11B-10-K
Company: ELI LILLY & CoTicker: LLYSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →